*DABIGATREX* Steris Healthcare The newer flagship product *Dabigatrex* Dabigatran is THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.
Dabigatran therapy has been associated with a low rate of serum enzyme elevations and rare instances of liver enzyme elevations and jaundice
MARKET BRAND LEADERS
*PRADAXA.....................Boehringer*
AFOGATRAN...............TORRENT
DABISTAR...................LUPIN
DABIGZA......................GLENMARK
DABLEXA.....................ABBOTT